Minerva Neurosciences (NERV) Institutional Ownership $1.92 +0.06 (+2.94%) Closing price 08/1/2025 03:45 PM EasternExtended Trading$1.92 0.00 (0.00%) As of 08/1/2025 04:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Minerva Neurosciences (NASDAQ:NERV)CurrentInstitutional OwnershipPercentage34.56%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$84.69KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$96.71K Get NERV Insider Trade Alerts Want to know when executives and insiders are buying or selling Minerva Neurosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NERV Institutional Buying and Selling by Quarter Minerva Neurosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/10/2025 Apella Capital LLC20,625$35K0.0%N/A0.295% 2/17/2025Citadel Advisors LLC25,764$57K0.0%+49.5%0.369% 2/14/2025Northern Trust Corp36,878$82K0.0%+60.0%0.528% 2/13/2025Renaissance Technologies LLC128,100$285K0.0%-18.5%1.833% 8/9/2024Renaissance Technologies LLC167,700$535K0.0%-5.7%2.398% 11/13/2023Acadian Asset Management LLC17,423$120K0.0%-18.8%0.249% 8/7/2023Acadian Asset Management LLC21,463$195K0.0%-24.3%0.307% 7/27/2023Virtu Financial LLC20,993$192K0.0%N/A0.377% 11/14/2022Point72 Asset Management L.P.25,000$231K0.0%N/A0.468% 10/26/2022 Truist Financial Corp11,043$102K0.0%N/A0.207% Get the Latest News and Ratings for NERV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Minerva Neurosciences and its competitors with MarketBeat's FREE daily newsletter. 9/16/2022Federated Hermes Inc.1,201,275$3.98M0.0%-87.5%22.496% 2/10/2022Acadian Asset Management LLC1,768,685$1.41M0.0%+3.4%4.140% 11/16/2021Two Sigma Securities LLC16,788$29K0.0%N/A0.039% 11/15/2021Dimensional Fund Advisors LP740,056$1.29M0.0%-30.7%1.732% 11/15/2021 GSA Capital Partners LLP480,629$836K0.1%+26.0%1.125% 11/12/2021Renaissance Technologies LLC754,116$1.31M0.0%-24.7%1.765% 11/12/2021Connor Clark & Lunn Investment Management Ltd.143,761$250K0.0%+33.3%0.337% 11/10/2021Rafferty Asset Management LLC48,865$85K0.0%N/A0.114% 11/9/2021BlackRock Inc.488,370$850K0.0%+20.2%1.143% 11/2/2021Raymond James Financial Services Advisors Inc.17,000$30K0.0%-54.1%0.040% 10/19/2021 Assenagon Asset Management S.A.1,082,333$1.88M0.0%+44.5%2.533% 9/17/2021Virtu Financial LLC15,389$36K0.0%N/A0.036% 8/17/2021Millennium Management LLC1,294,444$3.00M0.0%+126.5%3.030% 8/17/2021Bridgeway Capital Management LLC89,200$207K0.0%-61.8%0.209% 8/16/2021Squarepoint Ops LLC15,578$36K0.0%N/A0.036% 8/16/2021AQR Capital Management LLC52,822$123K0.0%-69.3%0.124% 8/16/2021LMR Partners LLP31,189$72K0.0%N/A0.073% 8/16/2021State Street Corp110,632$257K0.0%-80.6%0.259% 8/16/2021Tibra Equities Europe Ltd136,100$316K0.1%N/A0.319% 8/16/2021Goldman Sachs Group Inc.97,564$227K0.0%-89.8%0.228% 8/13/2021Renaissance Technologies LLC1,001,844$2.32M0.0%+128.2%2.345% 8/13/2021Northern Trust Corp68,097$158K0.0%-81.5%0.159% 8/13/2021Jump Financial LLC65,600$153K0.0%N/A0.154% 8/13/2021Qube Research & Technologies Ltd15,329$36K0.0%N/A0.036% 8/13/2021Geode Capital Management LLC445,779$1.03M0.0%-35.8%1.043% 8/13/2021Vanguard Group Inc.4,098,851$9.51M0.0%-7.3%9.594% 8/12/2021XTX Topco Ltd34,202$79K0.0%N/A0.080% 8/12/2021Dimensional Fund Advisors LP1,067,481$2.48M0.0%-1.9%2.499% 8/12/2021JPMorgan Chase & Co.118,560$275K0.0%-36.0%0.278% 8/12/2021Ergoteles LLC162,100$376K0.0%N/A0.379% This Crypto Is Set to Explode in January (Ad)Free summit reveals where Bitcoin goes after $120k Don't miss this rare opportunity to learn directly from the experts who are driving this market…Reserve your free spot now.8/12/2021Connor Clark & Lunn Investment Management Ltd.107,874$250K0.0%+10.3%0.253% 8/11/2021Bank of New York Mellon Corp30,757$71K0.0%-74.4%0.072% 8/11/2021Deutsche Bank AG114,523$266K0.0%+16.6%0.268% 8/5/2021Los Angeles Capital Management LLC49,945$116K0.0%-73.3%0.117% 8/5/2021 GSA Capital Partners LLP381,488$885K0.1%+187.5%0.893% 8/4/2021Russell Investments Group Ltd.94,688$218K0.0%-7.6%0.222% 5/18/2021Millennium Management LLC571,601$1.67M0.0%+40.6%1.338% 5/18/2021D. E. Shaw & Co. Inc.93,143$272K0.0%-7.6%0.218% 5/18/2021Morgan Stanley929,176$2.71M0.0%+92.2%2.175% 5/18/2021Cubist Systematic Strategies LLC17,598$51K0.0%+49.2%0.041% 5/18/2021Jane Street Group LLC15,088$44K0.0%+26.4%0.035% 5/18/2021California State Teachers Retirement System53,432$156K0.0%+6.2%0.125% 5/17/2021AQR Capital Management LLC172,018$502K0.0%-16.5%0.403% 5/17/2021Price T Rowe Associates Inc. MD59,008$172K0.0%N/A0.138% 5/17/2021Nuveen Asset Management LLC122,679$1.65M0.0%-2.6%0.287% 5/14/2021Dimensional Fund Advisors LP1,088,211$3.18M0.0%-4.0%2.547% (Data available from 1/1/2016 forward) NERV Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NERV shares? During the previous two years, the following institutional investors and hedge funds held shares of Minerva Neurosciences shares: Renaissance Technologies LLC ($285K), Acadian Asset Management LLC ($120K), Northern Trust Corp ($82K), and Citadel Advisors LLC ($57K), Apella Capital LLC ($35K).Learn more on Minerva Neurosciences' institutional investors. What percentage of Minerva Neurosciences' stock is owned by institutional investors? 34.56% of Minerva Neurosciences' stock is owned by institutional investors. Learn more on NERV's institutional investor holdings. Which institutional investors have been buying Minerva Neurosciences' stock? The following institutional investors have purchased Minerva Neurosciences' stock in the last 24 months: Apella Capital LLC ($20.63K), Northern Trust Corp ($13.83K), and Citadel Advisors LLC ($8.53K). How much institutional buying is happening at Minerva Neurosciences? Institutional investors have bought a total of 42,979 shares in the last 24 months. This purchase volume represents approximately $84.69K in transactions. Which of Minerva Neurosciences' major shareholders have been selling company stock? The following institutional investors have sold Minerva Neurosciences stock in the last 24 months: Renaissance Technologies LLC ($39.17K). How much institutional selling is happening at Minerva Neurosciences? Institutional investors have sold a total of 39,165 shares in the last 24 months. This volume of shares sold represents approximately $96.71K in transactions. Related Companies Renovaro Major Shareholders Kronos Bio Major Shareholders vTv Therapeutics Major Shareholders Actinium Pharmaceuticals Major Shareholders PDS Biotechnology Major Shareholders Annovis Bio Major Shareholders Precision BioSciences Major Shareholders Senti Biosciences Major Shareholders NRx Pharmaceuticals Major Shareholders Exicure Major Shareholders This page (NASDAQ:NERV) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Minerva Neurosciences, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Minerva Neurosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
